- Report
- May 2025
- 150 Pages
Global
From €5277EUR$5,950USD£4,577GBP
- Report
- August 2025
- 184 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 182 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 192 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 193 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 183 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 192 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 197 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 192 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 182 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 185 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 180 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 185 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 180 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 189 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 182 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 191 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 183 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 195 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- February 2025
- 200 Pages
Global
From €3982EUR$4,490USD£3,454GBP

Quality by Design (QbD) is a systematic approach to pharmaceutical manufacturing that focuses on product and process understanding, design, and control. It is based on the principles of risk management and quality assurance, and is intended to ensure that products meet their intended quality, safety, and efficacy requirements. QbD is a holistic approach to product development that involves the integration of product and process design, development, and control. It is a proactive approach to product development that seeks to identify and address potential risks before they become problems.
QbD is becoming increasingly important in the pharmaceutical industry, as it helps to ensure that products are safe and effective. It also helps to reduce costs associated with product development and manufacturing, as well as improve product quality and consistency.
Some companies in the QbD market include Merck, Pfizer, Novartis, GlaxoSmithKline, AstraZeneca, and Sanofi. Show Less Read more